Alpine-Bio ApS: Financial statements 2024
CVR: 44607379
Alpine-Bio ApS (CVR 44607379) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 94,889 and a net result of DKK -156,738. Equity amounted to DKK 383,262. The solvency ratio was 19.3%. The company had 1 employee in the financial year.
- Gross Profit
- 94,889 kr.
- Profit/Loss
- -156,738 kr.
- Equity
- 383,262 kr.
- Total Assets
- 1,989,661 kr.
- Employees
- 1
How creditworthy is Alpine-Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of February 1, 2024, Søren Anker Nielsen is registered as director of Alpine-Bio ApS.
Alpine-Bio ApS was founded on February 1, 2024.
About Alpine-Bio ApS
Alpine-Bio ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Søren Anker Nielsen. The company is owned by JUUZ ApS and S21 Holding ApS. In 2025, the company reported a gross profit of DKK 179,268 and a net result of DKK -61,697 compared with DKK -156,738 the year before. Equity amounted to DKK 621,565.
